Company Overview - FibroBiologics, Inc. is a clinical-stage biotechnology company based in Houston, focusing on developing therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials [3] - The company holds over 270 patents issued and pending in the US and internationally, covering various clinical pathways such as wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer [3] Upcoming Events - The CEO, Pete O'Heeron, will present at the DealFlow Discovery Conference on January 28-29, 2026, in Atlantic City, New Jersey [1] - FibroBiologics will deliver a company presentation on January 29 at 11:30 a.m. ET and will be available for one-on-one investor meetings throughout the event [2]
FibroBiologics to Present at the DealFlow Discovery Conference